Entering text into the input field will update the search result below

Supernus Pharmaceuticals misses by $0.04, misses on revenue

  • Supernus Pharmaceuticals (NASDAQ:SUPN): Q1 EPS of $0.19 misses by $0.04.
  • Revenue of $56.37M (+31.0% Y/Y) misses by $3.02M.
  • Press Release

Recommended For You

About SUPN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SUPN--
Supernus Pharmaceuticals, Inc.